Access cutting-edge asthma treatment through this clinical trial at a research site in Dothan. Study-provided care at no cost to qualified participants.
Access asthma specialists in Dothan at no cost
This study follows strict safety protocols and ethical guidelines
All study-related asthma treatment provided free
The primary objective of the study is to assess the efficacy of high dose and low dose fluticasone propionate (Fp)/albuterol sulfate (ABS) integrated electronic module multidose dry powder inhaler (eMDPI) compared to ABS eMDPI in decreasing severe clinical asthma exacerbation (CAEs). Secondary Objectives: To evaluate the efficacy of Fp/ABS compared to ABS and the effect on systemic corticosteroid (SCS) exposure To evaluate the safety and tolerability of Fp/A BS The duration for each particip
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Check if you qualify for this asthma clinical trial in Dothan, AL
If you're searching for asthma treatment options in Dothan, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Dothan research site is actively enrolling participants for this clinical trial. You'll receive care from experienced asthma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.